AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Parainfluenza type 3 vaccine safe and effective in children.

Vaccine Weekly

| March 31, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 MAR 31 - (NewsRx.com & NewsRx.net) -- Parainfluenza type 3 cold passage mutant 45 live attenuated vaccine was safe and effective in healthy children 6 to 18 months old.

"A phase 2 evaluation of live attenuated parainfluenza type 3 (PIV3) -cold passage mutant 45 (cp45) vaccine was conducted in 380 children 6 to 18 months old; 226 children (59%) were seronegative for PIV3. Of the 226 seronegative children, 114 received PIV3-cp45 vaccine, and 112 received placebo. No significant difference in the occurrence of adverse events (i.e., runny nose, cough, or temperature greater than or equal to38 degrees C) was noted during the 14 days after vaccination," scientists in the United States and Australia report.

"There was no difference between groups in the occurrence of acute otitis media or serous otitis media," said Robert B. Belshe at St. Louis University in the United States and collaborators in the United States and Australia. "Paired serum samples were available for 109 of the seronegative vaccine recipients and for 110 of the seronegative placebo recipients; 84% of seronegative vaccine recipients developed a greater than or equal to four-fold increase in antibody titers. The ...

Related articles from newspapers, magazines, journals, and more
Dengue edges in to U.S., especially Texas, Florida.(Infectious Diseases)(United...
Magazine article from: Family Practice News McNamara, Damian June 1, 2008 700+ words
...central and southern United States, he said. Dr...of the continental United States in a Jan. 9, 2008...Institute of Allergy and Infectious Diseases, where Dr. Morens...introduction into the United States in 1985, Aedes albopictus...
Xenomics' Patent Applications for the Diagnosis and Monitoring of Infectious...
Press release article from: PR Newswire August 24, 2006 700+ words
...published by the United States Patent and...and monitor infectious diseases, such as...sponsored by the United States Centers for...to include infectious diseases caused by...Typically, United States patent applications...
Weeds.(ANOTHER DIMENSION)(infectious diseases)(United States Centers for...
Magazine article from: Emerging Infectious Diseases Valdiserri, Ronald O. June 1, 2006 700+ words
The even mead, that erst brought sweetly forth The freckled cowslip, burnet, and green clover, Wanting the scythe, all uncorrected, rank, Conceives by idleness, and nothing teems But hateful docks, rough thistles, kecksies, burs, Losing both beauty and utility. --William Shakespeare Henry V
Incidence of sepsis continues to rise in the United States.(Infectious Diseases)
Magazine article from: Family Practice News Brunk, Doug October 15, 2005 700+ words
...The incidence of severe sepsis in the United States rose from about 10 cases per 100...10th most common cause of death in the United States, and it's increasing in incidence...635 cases of severe sepsis in the United States. Over that period the incidence increased...
Peregrine Pharmaceuticals and the United States Army Medical Research Institute...
Press release article from: PR Newswire July 21, 2005 700+ words
...CRADA) for Material Transfer with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) to evaluate the potential...trial at multiple clinical sites in the United States. About Tarvacin(TM) Anti-Phospholipid...
Tentacle probe offers assurance for anthrax detection; joint study from Arcxis...
News wire article from: Chemical Business Newsbase February 28, 2007 700+ words
...From Chemical Business NewsBase - Press Release) Arcxis Biotechnologies (Arcxis) and United States Army Medical Research Institute of Infectious Diseases announced the successful conclusion of their recent joint collaboration using Arcxis...
Recommended immunization schedule for ages 0-6 years: United States *...
Magazine article from: Family Practice News January 1, 2007 700+ words
Recommended Immunization Schedule for Ages 0-6 Years UNITED STATES * 2007 DEPARTMENT OF HEALTH AND HUMAN SERVICES * CENTERS FOR DISEASE CONTROL AND PREVENTION Age Birth 1 2 Vaccine month months...
Recommended immunization Schedule for Ages 7-18 years: United States *...
Magazine article from: Family Practice News January 1, 2007 700+ words
Recommended Immunization Schedule for Ages 7-8 Years UNITED STATES * 2007. DEPARTMENT OF HEALTH AND HUMAN SERVICES * CENTERS FOR DISEASE CONTROL AND PREVENTION Age 7-10 11-12 13-14 Vaccine...
University lab halts Ebola research.(Infectious diseases)(University of...
Magazine article from: Medical Laboratory Observer November 1, 2007 700+ words
After the National Institutes of Health (NIH) alerted a University of Wisconsin-Madison research lab a year ago that its federally funded Ebola research was being conducted in a lab not properly secure to handle the virus, the study was immediately moved to a more secure Canadian lab. Ebola
US NFID welcomes new infection control policy including flu vacc.(United states...
Newspaper article from: Pharma Marketletter June 26, 2006 700+ words
The USA-based National Foundation for Infectious Diseases has welcomed the Joint Commission on Accreditation of Healthcare Organizations for introducing a new infection conrol policy that...
For more facts and information, see all results

Source: HighBeam Research, Parainfluenza type 3 vaccine safe and effective in children.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA